Table 4.
Changes in liver steatosis
| Variable | DASH (N = 20) |
Control (N = 20) |
P* |
|---|---|---|---|
| NAFLD severity | |||
| Baseline | 0.273 | ||
| Grade I | 10(50.0) | 8 (40.0) | |
| Grade II | 10 (50.0) | 12 (60.0) | |
| End | |||
| Grade 0 | 12 (60.0) | 4(20.0) | 0.012 |
| Grade I | 8 (40.0) | 12 (60.0) | |
| Grade II | 0 (0.0) | 4 (20.0) | |
| Liver steatosis severity | |||
| No change | 1 (5.0) | 12 (60.0) | |
| 1 grade reduction | 16 (80.0) | 8(40.0) | |
| 2 grade reduction | 3 (15.0) | 0 (0.0) | |
| ARR | |||
| 1 grade reduction (%) | 40 | – | |
| 2 grade reduction (%) | 15 | – | |
| NNT | |||
| 1 grade reduction | 2.5 | – | |
| 2 grade reduction | 6.67 | – | |
Bold indicate p < 0.05 is statistically significant
*Chi square test
DASH, Dietary Approaches to Stop Hypertension; Non-alcoholic fatty liver disease; ARR, Attributable risk reduction; NNT, Number needed to treat